IRADIMED CORP

IRMD

Form 4 • Statement of Changes in Beneficial Ownership

SEC Accession Number: 0002047489-26-000002
Filing date: Mar 5, 2026
Earliest execution date: Mar 3, 2026

Summary

Type

Neutral

Net shares

0

% of shares

0.00%

Amount (USD)

$0

Insider confidence score

52.5 out of 100

Positive

  • Minimal sell amount (<$10K)

Derivative Transactions

Transaction 1

Security

Restricted Stock Units

Action

Grant

Date

2026-03-03

Code

A

Net shares

+1,150.0

Acquired/Disposed

Acquired

Shares Owned Before

0.0

Shares Owned After

1,150.0

Filing's footnotes

1. Restricted stock units (&quot;RSUs&quot;) convert into common stock on a one-for-one basis.

2. The reporting person received RSUs under Iradimed Corporation's 2023 Equity Incentive Plan. The RSUs vest in three equal annual installments beginning on December 7, 2026. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested.

This page is for informational purposes only. While we strive for accuracy, the summary may contain inaccuracies or omissions. Please refer to the official SEC filing for authoritative information. Open the SEC filing.